Correlation between the prognostic value and the expression of the stem cell marker CD133 and isocitrate dehydrogenase1 in glioblastomas (Q48931499)

16 February 2018

title

Correlation between the prognostic value and the expression of the stem cell marker CD133 and isocitrate dehydrogenase1 in glioblastomas (English)

1 reference

16 February 2018

author name string

Jung Ha Shin

1

1 reference

16 February 2018

Youn Soo Lee

2

1 reference

16 February 2018

Yong-Kil Hong

3

1 reference

16 February 2018

Chang Suk Kang

4

1 reference

16 February 2018

publication date

16 October 2013

1 reference

16 February 2018

Journal of Neuro-Oncology

published in

1 reference

16 February 2018

volume

115

1 reference

16 February 2018

issue

3

1 reference

16 February 2018

page(s)

333-341

1 reference

16 February 2018

Biology of glioma cancer stem cells

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1234-Z

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1234-Z

Identification of human brain tumour initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1234-Z

Stem cell marker CD133 affects clinical outcome in glioma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1234-Z

Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1234-Z

Presence of pluripotent CD133+ cells correlates with malignancy of gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1234-Z

Chemotherapy resistance of glioblastoma stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1234-Z

Molecular analysis of ex-vivo CD133+ GBM cells revealed a common invasive and angiogenic profile but different proliferative signatures among high grade gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1234-Z

Making a tumour's bed: glioblastoma stem cells and the vascular niche.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1234-Z

High-grade glioma before and after treatment with radiation and Avastin: initial observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1234-Z

Detection of IDH1 mutation in human gliomas: comparison of immunohistochemistry and sequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1234-Z

Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1234-Z

CD133 as a marker for cancer stem cells: progresses and concerns

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1234-Z

Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1234-Z

Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1234-Z

Inconsistent immunohistochemical expression patterns of four different CD133 antibody clones in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1234-Z

Prognostic impact of CD133 mRNA expression in 48 glioblastoma patients treated with concomitant radiochemotherapy: a prospective patient cohort at a single institution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1234-Z

IDH1 and IDH2 mutations in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1234-Z

IDH mutations in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1234-Z

IDH1 mutations in oligodendroglial tumors: comparative analysis of direct sequencing, pyrosequencing, immunohistochemistry, nested PCR and PNA-mediated clamping PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1234-Z

Detection and comparison of peptide nucleic acid-mediated real-time polymerase chain reaction clamping and direct gene sequencing for epidermal growth factor receptor mutations in patients with non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1234-Z

Detection of low-level KRAS mutations using PNA-mediated asymmetric PCR clamping and melting curve analysis with unlabeled probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1234-Z

IDH mutation status impact on in vivo hypoxia biomarkers expression: new insights from a clinical, nuclear imaging and immunohistochemical study in 33 glioma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1234-Z

Neoplastic cells are a rare component in human glioblastoma microvasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1234-Z

Correlation between glioblastoma stem-like cells and tumor vascularization

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24129546

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Expression of glioma stem cell marker CD133 and O6-methylguanine-DNA methyltransferase is associated with resistance to radiotherapy in gliomas

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24129546

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Current strategies for identification of glioma stem cells: adequate or unsatisfactory?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24129546

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11060-013-1234-Z

1 reference

16 February 2018

1 reference

16 February 2018